Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial.

Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial. JACC Cardiovasc Interv. 2009 Nov; 2(11):1083-91.

View in: PubMed

subject areas

Aged
Angioplasty, Balloon, Coronary
Anticoagulants
Australia
Canada
Enoxaparin
Europe
Female
Fibrinolytic Agents
Hemorrhage
Heparin
Humans
Injections, Intravenous
Kaplan-Meier Estimate
Male
Middle Aged
Myocardial Infarction
New Zealand
Platelet Aggregation Inhibitors
Proportional Hazards Models
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome
United States

authors with profiles

Robert Harrington